OKYO OKYO Pharma Limited

NASDAQ
$1.54

OKYO Pharma Limited (OKYO) has not yet scheduled its next earnings release.

Earnings Date
1st Quarter, Jun 2026
TBD
· Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About OKYO Pharma Limited

OKYO Pharma Limited is a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain. OKYO Pharma Limited is based in LONDON.

Sector

Healthcare

Industry

Biotechnology